Bruker Corp BRKR.OQ reported quarterly adjusted earnings of 32 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 52 cents. The mean expectation of thirteen analysts for the quarter was for earnings of 42 cents per share. Wall Street expected results to range from 38 cents to 49 cents per share.
Revenue fell 0.4% to $797.40 million from a year ago; analysts expected $811.37 million.
Bruker Corp's reported EPS for the quarter was 5 cents.
The company reported quarterly net income of $7.6 million.
Bruker Corp shares had fallen by 7.8% this quarter and lost 35.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 24.4% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Bruker Corp is $47.50, about 20% above its last closing price of $37.99
This summary was machine generated from LSEG data August 4 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.42 | 0.32 | Missed |
Mar. 31 2025 | 0.43 | 0.47 | Beat |
Dec. 31 2024 | 0.74 | 0.76 | Beat |
Sep. 30 2024 | 0.59 | 0.60 | Beat |